Head and neck cancer fungating wounds: a novel odour transferrer.

Autor:	Ota H; Otolaryngology Head and Neck Surgery, Niigata University Faculty of Medicine Graduate School of Medical and Dental Science, Niigata, Japan., Ueki Y; Otolaryngology Head and Neck Surgery, Niigata University Faculty of Medicine Graduate School of Medical and Dental Science, Niigata, Japan ucuekin@gmail.com., Yamazaki K; Otolaryngology Head and Neck Surgery, Niigata University Faculty of Medicine Graduate School of Medical and Dental Science, Niigata, Japan., Shodo R; Otolaryngology Head and Neck Surgery, Niigata University Faculty of Medicine Graduate School of Medical and Dental Science, Niigata, Japan., Takahashi T; Otolaryngology Head and Neck Surgery, Niigata University Faculty of Medicine Graduate School of Medical and Dental Science, Niigata, Japan., Yokoyama Y; Otolaryngology Head and Neck Surgery, Niigata University Faculty of Medicine Graduate School of Medical and Dental Science, Niigata, Japan., Horii A; Otolaryngology Head and Neck Surgery, Niigata University Faculty of Medicine Graduate School of Medical and Dental Science, Niigata, Japan.
Jazyk:	angličtina
Zdroj:	BMJ supportive & palliative care [BMJ Support Palliat Care] 2024 Jan 08; Vol. 13 (e3), pp. e833-e835. Date of Electronic Publication: 2024 Jan 08.
DOI:	10.1136/spcare-2022-003824
Abstrakt:	Objective: The management for malodour of malignant fungating wounds (MFWs) in head and neck cancer (HNC) is unestablished. We evaluated the effects of a novel odour transferrer on malodour generated by MFWs in patients with HNC. Methods: A spray-type odour transferrer approved by the Japanese government for safe use in humans produces a good scent by binding to bad odour. The odour of MFWs in 13 patients with HNC was scored by 37 medical staff and the patients' families using an odour scale ranging from 0 to 4 before and 1 week after application of the odour transferrer. Results: The odour score marked by all investigators (n=37), nurses (n=21) and doctors (n=11) decreased significantly (p<0.01). The odour score decreased by more than 2 points for 73% of all investigators after odour transferrer application. Conclusion: This novel odour transferrer functions as an effective deodorant for MFWs in patients with HNC. It can be used by non-medical staff and may benefit patients with bad odours arising from MFWs as well as their families and medical staff. Competing Interests: Competing interests: None declared. (© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu